QQ客服 官方微博 反馈留言

	Inferring new drug indications using the complementarity between clinical disease signatures and drug effects
	DongjinJang; DoheonLee; JaehyunLee; SejoonLee; KiseongKim
刊名	Journal of Biomedical Informatics
	2016
卷号	Vol.59页码:248-257
关键词	Drug repositioning Electronic clinical information Clinical disease signatures Clinical drug effects
ISSN号	1532-0464
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5410749
专题	上海电子信息职业技术学院
作者单位	1.a Department of Bio and Brain Engineering, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Republic of Korea 2.Bio-Synergy Research Center, 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Republic of Korea
推荐引用方式 GB/T 7714	DongjinJang,DoheonLee,JaehyunLee,et al. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects[J]. Journal of Biomedical Informatics,2016,Vol.59:248-257.
APA	DongjinJang,DoheonLee,JaehyunLee,SejoonLee,&KiseongKim.(2016).Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.Journal of Biomedical Informatics,Vol.59,248-257.
MLA	DongjinJang,et al."Inferring new drug indications using the complementarity between clinical disease signatures and drug effects".Journal of Biomedical Informatics Vol.59(2016):248-257.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。